Peter N. Dean
University of Virginia
13 Papers
37 Citations
Peter N. Dean is an academic researcher from University of Virginia. The author has contributed to research in topics: Medicine & Athletes. The author has an hindex of 3, co-authored 13 publications.
Chat about Author
Papers
Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review
Matthew W. Martinez,Jonathan H. Kim,Ankit B. Shah,Dermot Phelan,Michael S. Emery,Meagan M. Wasfy,Antonio B. Fernandez,T. Jared Bunch,Peter N. Dean,Alfred Danielian,Sheela Krishnan,Aaron L. Baggish,Thijs M. H. Eijsvogels,Eugene H. Chung,Benjamin D. Levine +14 more
TL;DR: In this article, the effects of exercise on the heart, the approach to common clinical scenarios in sports cardiology, and the importance of a patient/athlete-centered, shared decision-making approach in the care provided to athletes are discussed.
82
Coronary Artery Evaluation by Screening Echocardiogram in Intercollegiate Athletes.
Walter J. Hoyt,Peter N. Dean,Daniel Scott Schneider,Mark R. Conaway,Christopher M. Kramer,Robert W. Battle +5 more
TL;DR: The origin and proximal course of the coronary arteries were readily and reliably observed in the majority of athletes, suggesting coronary artery evaluation should be included in athlete screening TTE protocols.
16
Malrotation is not associated with adverse outcomes after cardiac surgery in patients with heterotaxy syndrome.
TL;DR: The outcomes following cardiac surgery for patients with HS are not impacted by the presence of malrotation and the incidence of volvulus in the studied group is low, and performing prophylactic Ladd procedures is not warranted.
15
Cardiopulmonary Bypass and Infant Vaccination Titers
Jeffrey Vergales,Peter N. Dean,Jacob Raphael,Deborah A. Frank,Adishesh K. Narahari,Tyson Hekking,Carol Ann Rosenberg,Mark E. Roeser,James J. Gangemi +8 more
TL;DR: Infant vaccine antibody titers were minimally affected by CPB and not associated with any easily modifiable surgical variables, suggesting deviation from the recommended vaccination schedule may be unnecessary for children requiring congenital heart surgery.
Congenital Heart Disease and the Athlete: What We Know and What We Do Not Know.
Peter N. Dean,Robert W. Battle +1 more
TL;DR: Since outcomes for patients with congenital heart disease (CHD) have greatly improved, most patients with CHD are surviving into adulthood and creating dilemmas for practitioners with regard to competitive sports participation.
4